On the recordSeptember 16, 2015
The questions are, the guidance on the statistical approaches to analytical similarity is particularly important as it impacts initial improvability as a biosimilar under the 351K.
Source
congress.govEditor's note · Context
Cassidy emphasizes the importance of guidance on statistical approaches for biosimilars.
Share
More from Bill Cassidy
Aug 14, 2026
I am concerned that IAM Union member dues are financing efforts to change U.S. policy related to the Cuban regime, a State Sponsor of Terror, instead of supporting American workers’ priorities.
Aug 18, 2026
You’ve lost sight of affordability for the parent. You’ve lost sight of the convenience for the American family. You’ve lost sight of that which is driving higher costs in healthcare — for example, more doctor’s visits
Aug 13, 2026
Protecting patient information is essential to delivering quality care.
Other voices in this conversation
